Filed pursuant to Rule 424B3
File No. 333-85632
PROSPECTUS SUPPLEMENT
Hypertension Diagnostics, Inc.
Offering of 2,356,073 Redeemable Class B Warrants
to Purchase Common Stock
On June 6, 2002, we commenced an offering of Redeemable Class B Warrants (the “Class B Warrant”) to the holders of our Redeemable Class A Warrants (the “Class A Warrant”) and the holders of our Units, which consist of one share of Common Stock and one Class A Warrant. When we refer to a “holder of a Class A Warrant,” we mean both the Unit holders and the Class A Warrant holders who are eligible to participate in this offering.
A Prospectus dated June 6, 2002, a Prospectus Supplement dated July 25, 2002 and a Prospectus Supplement dated September 11, 2002 all contain important information regarding the Class B Warrant offering. Class A Warrant holders should read the Prospectus dated June 6, 2002, the Prospectus Supplements dated July 25, 2002 and September 11, 2002 and this Prospectus Supplement dated October 17, 2002 before deciding to invest.
This Prospectus Supplement supplements and supercedes the Prospectus dated June 6, 2002 and the Prospectus Supplements dated July 25, 2002 and September 11, 2002 only as follows:
Extension of Expiration of Offering
and
Extension of Expiration of the Class A Warrant
• | This offering of Class B Warrants has been extended from 5:00 p.m. Central Time on October 22, 2002 to 5:00 p.m. Central Time on November 14, 2002. | |
• | The expiration date of the Class A Warrant has been likewise extended from 5:00 p.m. Central Time on October 22, 2002 to 5:00 p.m. Central Time on November 14, 2002. |
Exercise Price of Class A Warrant and Class B Warrant Reduced
• | We have reduced the exercise prices of each of the Class A Warrant and the Class B Warrant. These exercise price reductions are effective as of the date of this Prospectus Supplement and will continue to be in effect until the respective expiration dates of the Class A Warrant and the Class B Warrant. | |
• | The exercise price per share of our Common Stock issuable upon exercise of the Class A Warrant has been reduced from $1.25 to $1.00. The exercise price per share of our Common Stock issuable upon exercise of the Class B Warrant has been reduced from $1.50 to $1.00. |
This Prospectus Supplement is Dated October 17, 2002.